Integrase Inhibitors Linked to Higher Cardiometabolic Risk in HIV Patients
|
A secondary analysis of the REPRIEVE study found that
among people living with HIV on stable antiretroviral therapy and with
low-to-moderate ... |
Nigeria Begins HIV Prevention Injection Rollout
Nigeria has begun preparations to roll out Lenacapavir, a long-acting injectable HIV prevention drug, across eight states and the Federal Capital ... View article...